Metraipolis › archive › dc_4e28714c28ce

Predictors of Response to Imatinib Therapy and Long-Term Outcomes in Paediatric and Adolescent Patients With Chronic Myeloid Leukaemia — Europe PMC PMID:41496461

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41496461
DOI
10.1002/cnr2.70430
License (as archived)
solo-consultazione
Archived
2026-11-07T05:11:13.794Z
SHA-256 of the archived text
0c10a4b6d3294cdc02d032ac843d3eb94184bb23756f538f0db25dcf8ec72ec2
Stable URL of this page
https://metraipolis.com/documento/dc_4e28714c28ce

How to cite

Predictors of Response to Imatinib Therapy and Long-Term Outcomes in Paediatric and Adolescent Patients With Chronic Myeloid Leukaemia — Europe PMC PMID:41496461 — Europe PMC (en), https://europepmc.org/article/MED/41496461 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e28714c28ce (Metraipolis archive dc_4e28714c28ce, sha256 0c10a4b6d3294cdc02d032ac843d3eb94184bb23756f538f0db25dcf8ec72ec2)
BibTeX
@misc{dc4e28714c28ce,
  title = {Predictors of Response to Imatinib Therapy and Long-Term Outcomes in Paediatric and Adolescent Patients With Chronic Myeloid Leukaemia — Europe PMC PMID:41496461},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41496461},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e28714c28ce; sha256 0c10a4b6d3294cdc02d032ac843d3eb94184bb23756f538f0db25dcf8ec72ec2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41496461. Agents can read the archived copy with the MCP tool read_document.